Armis, the cyber exposure management & security company, today announced it has been selected as a launch partner for the Torq AMP alliance program, designed to drive agentic AI innovation. Armis was chosen due to its leading Cyber Exposure Management Platform, Armis CentrixTM, that seamlessly integrates with Torq’s SecOps platform to empower customers and their SOC/Incident Response teams. “As the leader in Cyber Exposure Management, Armis is redefining how organizations understand, prio...

IntraBio Inc., a biopharmaceutical company focused on developing therapies for rare neurological diseases, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of AQNEURSA® (levacetylleucine) for the treatment of Niemann-Pick disease type C (NPC). "This positive CHMP opinion represents another important milestone in expanding access to AQNEURSA to the global NPC community," said Dr....